Log In
person
BioNTech SE
BNTX
summarize
2 total product lines
calendar_month
Revenue as of 12/31/2023
| Reporting Segmentarrow_drop_up | Product Line | Amount (EUR) | Percentage |
|---|---|---|---|
| keyboard_arrow_right | Reporting Segment & Product Line | Amount (EUR) | Percentage |
| Therapies and Vaccines |
Infectious Disease Vaccines
These companies make vaccines targeting infectious diseases.
|
3.82B | 99.91% |
| Therapies and Vaccines |
Pre-Revenue Pharmaceuticals
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
0B | 0.09% |
| keyboard_arrow_down |
Therapies and Vaccines
Infectious Disease Vaccines
|
3.82B | 99.91% |
| keyboard_arrow_right |
These companies make vaccines targeting infectious diseases.
|
||
| keyboard_arrow_down |
Therapies and Vaccines
Pre-Revenue Pharmaceuticals
|
0B | 0.09% |
| keyboard_arrow_right |
These companies research and develop pharmaceuticals, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
|
||